Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia

Blood. 2006 Oct 1;108(7):2237-43. doi: 10.1182/blood-2006-02-005991. Epub 2006 Jun 27.

Abstract

Hyperhomocysteinemia is a risk factor for thrombosis, but the mechanisms are not well defined. We tested the hypothesis that hyperhomocysteinemia accelerates arterial thrombosis in mice. Mice heterozygous for a targeted disruption of the cystathionine beta-synthase gene (Cbs+/-) and wild-type littermates (Cbs+/+) were fed either a control diet or a high methionine/low folate (HM/LF) diet for 6 to 8 months to produce graded hyperhomocysteinemia. The time to occlusion of the carotid artery after photochemical injury was shortened by more than 50% in Cbs+/+ or Cbs+/- mice fed the HM/LF diet (P < .001 versus control diet). Carotid artery thrombosis was not accelerated in mice deficient in endothelial nitric oxide synthase (Nos3), which suggests that decreased endothelium-derived nitric oxide is not a sufficient mechanism for enhancement of thrombosis. Cbs+/+ and Cbs+/- mice fed the HM/LF diet had elevated levels of reactive oxygen species in the carotid artery, increased aortic expression of the NADPH oxidase catalytic subunit, Nox4, and decreased activation of anticoagulant protein C in the aorta (P < .05 versus control diet). We conclude that hyperhomocysteinemia enhances susceptibility to arterial thrombosis through a mechanism that is not caused by loss of endothelium-derived nitric oxide but may involve oxidative stress and impairment of the protein C anticoagulant pathway.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Anticoagulants / metabolism
  • Carotid Arteries / pathology*
  • Cystathionine beta-Synthase / genetics
  • Genetic Predisposition to Disease*
  • Hyperhomocysteinemia / diagnosis*
  • Hyperhomocysteinemia / genetics*
  • Hyperhomocysteinemia / pathology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Nitric Oxide Synthase Type II / metabolism
  • Nitric Oxide Synthase Type III
  • Reactive Oxygen Species
  • Thrombosis / pathology*

Substances

  • Anticoagulants
  • Reactive Oxygen Species
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse
  • Cystathionine beta-Synthase